Skip to main content
Premium Trial:

Request an Annual Quote

Reaction Biology Wins SBIR Grant for Microarray-Based Kinase Screening

NEW YORK, June 21 (GenomeWeb News) - Reaction Biology has been awarded a Phase I Small Business Innovation Research grant from the National Institutes of Health to develop its microarray kinase screening technology for testing compounds in nanoliter reactions, the company said today.

 

According to Reaction Biology, the grant funds the use of its DiscoveryDot microarray technology for high-throughput kinase screening.

 

RBC also said that it eventually plans to expand its assay range across the human kinome.

 

The company did not disclose the amount of the award, but an NIH database lists a grant for Reaction Biology, entitled, "Kinome Drug Bioassay Platform," in the amount of $100,000.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.